Home
About
Overview
Sharing Data
ORCID
Help
History (5)
1-Acylglycerophosphocholine O-Acyltransferase
Body Height
Coagulants
Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension Study.
Respiratory Tract Fistula
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension Study.
Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension Study. Arthritis Care Res (Hoboken). 2016 Apr; 68(4):534-43.
View in:
PubMed
subject areas
Adrenal Cortex Hormones
Adrenal Cortex Hormones
Adult
Adult
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Humanized
Brazil
Brazil
Disability Evaluation
Disability Evaluation
Drug Therapy, Combination
Drug Therapy, Combination
Europe
Europe
Female
Female
Humans
Humans
Immunosuppressive Agents
Immunosuppressive Agents
Lupus Erythematosus, Systemic
Lupus Erythematosus, Systemic
Male
Male
Middle Aged
Middle Aged
Quality of Life
Quality of Life
Severity of Illness Index
Severity of Illness Index
Surveys and Questionnaires
Surveys and Questionnaires
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
United States
United States
authors with profiles
Joan Merrill